financetom
Business
financetom
/
Business
/
Pan American Silver Swings to a Fourth-quarter Profit as Revenue Rises; 2025 Production Outlook Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pan American Silver Swings to a Fourth-quarter Profit as Revenue Rises; 2025 Production Outlook Issued
Feb 19, 2025 2:57 PM

05:30 PM EST, 02/19/2025 (MT Newswires) -- Pan American Silver ( PAAS ) slipped 1.2% in after-hour New York trading after the company on Wednesday said swung to a fourth-quarter profit on higher revenue.

The company's adjusted earnings, excluding most one-time items, stood at US$126.9 million, or US$0.35 per share, compared with a loss of US$16.3 million, or US$0.04 per share, in the year-ago quarter. FactSet expected US$0.36 per share.

Revenue rose to US$815.1 million from US$669.6 million. FactSet projected US$794.6 million.

For the quarter ended Dec. 31, silver production was 6-million ounces, and gold production was 224.2-thousand ounces.

For 2025, the company expects silver production to be between 20-million and 21-million ounces, and gold production to be between 735,000 and 800,000 ounces. It forecast all-in sustaining cost (AISC) for the Silver segment is between $16.25 and $18.25 per ounce and for the Gold segment between $1,525 and $1,625 per ounce.

The company declared a cash dividend of $0.10 per common share, payable on or about March 14 to holders of record as of March 3.

The company's shares were last seen down US$0.29 to US$24.03 after hours. They closed down $0.42 to $34.59 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trump faces pressure from US industry over China tariff on medicines
Trump faces pressure from US industry over China tariff on medicines
Feb 6, 2025
* Lobby groups say tariffs could lead to drug shortages * Cancer and heart medicines, antibiotics come from China * Pharmaceuticals have often been exempt from tariffs By Michael Erman, Patrick Wingrove Feb 6 (Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new tariffs on Chinese imports, as...
Canadian oil producer Suncor well-protected against tariff threat, CEO says
Canadian oil producer Suncor well-protected against tariff threat, CEO says
Feb 6, 2025
CALGARY, Feb 6 (Reuters) - Canadian oil producer Suncor Energy ( SU ) is well-positioned compared to many of its competitors to weather threatened U.S. tariffs, CEO Rich Kruger said on Thursday. On a conference call with analysts, Kruger said between 60% and 65% of Calgary, Alberta-based Suncor's production stays in Canada, either to be refined or shipped off the...
Trump faces pressure from US industry over China tariff on medicines
Trump faces pressure from US industry over China tariff on medicines
Feb 6, 2025
(Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new tariffs on Chinese imports, as they join big pharma lobbyists who have said such trade barriers will cause shortages of medicines and higher prices in the United States. The Republican president on Tuesday imposed the 10% tariffs on all...
Update: Calian Group Up 2.5% as It Signs Over $50 Million in Defense Contracts in Fiscal Q1
Update: Calian Group Up 2.5% as It Signs Over $50 Million in Defense Contracts in Fiscal Q1
Feb 6, 2025
11:42 AM EST, 02/06/2025 (MT Newswires) -- (Updates shares.) Calian Group ( CLNFF ) said Thursday that it signed over $50 million in new and renewed multi-year defense contracts in its fiscal first quarter. Of the almost 30 contracts, half will provide operational readiness training, including one for NATO's Joint Warfare Centre, Calian said. Under the terms, Calian will serve...
Copyright 2023-2026 - www.financetom.com All Rights Reserved